report from Biotechnica
Better single-use cross flow techs still needed says GE Healthcare
The biopharmaceutical manufacturing sector needs better cross flow filtration technologies according to GE Healthcare, which says that advances in bioreactor systems have not been matched downstream.
Call for topics
What do you think?
In which areas of the biopharmaceutical manufacturing process are new, better technologies needed?
Is connecting systems provided by different suppliers your biggest headache or do you hanker for improved chromatography systems?
Are today's cell lines good enough or do you think developers could do more?
BioPharma-reporter.com invites readers to suggest topics for future podcasts via the comment box below.
